Publication: Mycobacterium avium and Burkholderia pseudomallei (Melioidosis) coinfection in an HIV-positive patient
Issued Date
2006-12-01
Resource Type
ISSN
0125877X
Other identifier(s)
2-s2.0-33847378845
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.24, No.4 (2006), 239-243
Suggested Citation
Wadchara Pumpradit, Koya Ariyoshi, Wimol Petkanchanapong, Nuanjun Wichukchinda, Angkana Chaiprasert, Archawin Rojanawat, Pathom Sawanpanyalert, Panita Pathipvanich Mycobacterium avium and Burkholderia pseudomallei (Melioidosis) coinfection in an HIV-positive patient. Asian Pacific Journal of Allergy and Immunology. Vol.24, No.4 (2006), 239-243. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23450
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Mycobacterium avium and Burkholderia pseudomallei (Melioidosis) coinfection in an HIV-positive patient
Other Contributor(s)
Abstract
A 29 year old HIV positive Thai female with CD4 count of 10 cells/mm3 presented with chronic diffuse abdominal pain, fever, weight loss, anemia and leucopenia. Ultrasonography demonstrated diffuse upper abdominal lymphadenopathy with ascites. Microbiological and molecular work up of the specimen obtained by ultrasound-guided lymph node aspiration revealed co-infection with Burkholderia pseudomallei and Mycobacterium avium. Indirect hemagglutination, IgM-indirect fluorescent antibody, and IgG-indirect fluorescent antibody to Burkholderia pseudomallei were < 1:20, < 1:50 and < 1:50, respectively, at nine months, four months before the culture diagnosis and two months, eight months after the culture diagnosis of Burkholderia pseudomallei infection. The patient was treated initially with two weeks of intravenous ceftazidime, followed by oral cotrimoxazole, doxycycline and chloramphenicol. Clarithromycin and ofloxacin were added after the identification of Mycobacterium avium and its susceptibility test. The patients demonstrated clinical improvement with decreasing abdominal pain and resolution of fever.